MicroStrategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
LYRA Lyra Therapeutics
- 0.172
- -0.003-1.49%
Close Dec 24 13:00 ET
- 0.172
- +0.000+0.06%
Post 17:01 ET
11.28MMarket Cap-0.12P/E (TTM)
0.178High0.166Low610.74KVolume0.175Open0.175Pre Close105.11KTurnover1.46%Turnover RatioLossP/E (Static)65.46MShares6.79052wk High0.55P/B7.19MFloat Cap0.16352wk Low--Dividend TTM41.71MShs Float22.000Historical High--Div YieldTTM6.80%Amplitude0.163Historical Low0.172Avg Price1Lot Size
About Lyra Therapeutics Company
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.
Company Profile
SymbolLYRA
Company NameLyra Therapeutics
Listing DateMay 1, 2020
Issue Price16.00
Founded2005
CEODr. Maria Palasis, PhD
MarketNASDAQ
Employees145
Fiscal Year Ends12-31
Address480 Arsenal Way
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-393-4600
Company Executives
- Name
- Position
- Salary
- Dr. Maria Palasis, PhD
- Director, President and Chief Executive Officer
- 1.79M
- Jason Cavalier
- Chief Financial Officer, Treasurer and Principal Accounting Officer
- --
- Dr. Richard Nieman
- Chief Medical Officer
- --
- Dr. Harlan W. Waksal,M.D.
- Executive Chairman of the Board
- 625.06K
- C. Ann Merrifield
- Independent Director
- 113.06K
- W. Bradford Smith
- Independent Director
- 123.81K
- James R. Tobin
- Lead Independent Director
- 152.31K
- Dr. Nancy L. Snyderman, F.A.C.S.,M.D.
- Independent Director
- 109.06K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.